• 83 Citations
  • 2 Scopus h-Index
20152019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2015 2019

  • 83 Citations
  • 2 Scopus h-Index
  • 4 Article
  • 1 Review article
2019

Depomedroxyprogesterone acetate therapy for hot flashes in survivors of breast cancer: no unfavorable impact on recurrence and survival

Ertz-Archambault, N. M., Rogoff, L. B., Kosiorek, H. E., Ernst, B., Anderson, K. S., Pockaj, B. A., Gray, R. J. & Northfelt, D. W., Jan 1 2019, (Accepted/In press) In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Hot Flashes
Survivors
Acetates
Breast Neoplasms
Recurrence
2 Citations (Scopus)

Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer

McDonald, B. R., Contente-Cuomo, T., Sammut, S. J., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., Chin, S. F., Farooq, M., Mejia, R., Cronin, P. A., Anderson, K. S., Kosiorek, H. E., Northfelt, D. W., McCullough, A. E., Patel, B., Weitzel, J. N., Slavin, T. P., Caldas, C., Pockaj, B. A. & Murtaza, M., Aug 7 2019, In : Science translational medicine. 11, 504, eaax7392.

Research output: Contribution to journalArticle

Neoadjuvant Therapy
Breast Neoplasms
DNA
Neoplasms
Alleles
2018

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Lymphoma
Pharmaceutical Preparations
Maximum Tolerated Dose
Neutropenia
Hodgkin Disease
2015
34 Citations (Scopus)

Immunotherapy for the Treatment of Breast Cancer

Ernst, B. & Anderson, K. S., Jan 1 2015, In : Current oncology reports. 17, 2

Research output: Contribution to journalReview article

Immunotherapy
Breast Neoplasms
Cancer Vaccines
Neoplasm Antigens
Lung Neoplasms
47 Citations (Scopus)

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

Shanavas, M., Popat, U., Michaelis, L. C., Fauble, V., McLornan, D., Klisovic, R., Mascarenhas, J., Tamari, R., Arcasoy, M. O., Davies, J., Gergis, U., Ukaegbu, O. C., Kamble, R. T., Storring, J. M., Majhail, N. S., Romee, R., Verstovsek, S., Pagliuca, A., Vasu, S., Ernst, B. & 5 others, Atenafu, E. G., Hanif, A., Champlin, R., Hari, P. & Gupta, V., Sep 10 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Janus Kinase 1
Janus Kinase 2
Primary Myelofibrosis
Cell Transplantation
Behavior Therapy